e-learning
resources
Virtual 2021
05.09.2021
COVID - 19: lessons learned
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Usefulness of the ILD-GAP index in predicting COVID-19 pneumonia prognosis
S. Chakroun (Tunis, Tunisia), S. Mokaddem (Tunis, Tunisia), A. Chaker (Tunis, Tunisia), K. Kchaou (Tunis, Tunisia), S. Jameleddine (Tunis, Tunisia)
Source:
Virtual Congress 2021 – COVID - 19: lessons learned
Session:
COVID - 19: lessons learned
Session type:
E-poster
Number:
512
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Chakroun (Tunis, Tunisia), S. Mokaddem (Tunis, Tunisia), A. Chaker (Tunis, Tunisia), K. Kchaou (Tunis, Tunisia), S. Jameleddine (Tunis, Tunisia). Usefulness of the ILD-GAP index in predicting COVID-19 pneumonia prognosis. 512
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
Related content which might interest you:
Usefulness of shock index in severity assessment of community-acquired pneumonia
Source: Annual Congress 2007 - Miscellaneous lower respiratory tract infections
Year: 2007
Usefulness of shock index predictive value in mortality assessment in community acquired pneumonia
Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Year: 2013
Determining the best diagnostic biomarker for sepsis and prognosis assessment
Source: Annual Congress 2012 - Infections and sepsis in the ICU
Year: 2012
Biomarkers for the prognostic assessment and disease severity evaluation in community-acquired pneumonia (CAP)
Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity
Year: 2010
Admission lactate predicts poor prognosis independently of the CRB/CURB-65 scores in community-acquired pneumonia.
Source: International Congress 2017 – Update on community acquired pneumonia
Year: 2017
Validation of indices and predictive rules of severity for community-acquired pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 560s
Year: 2002
Criteria for predicting the course and outcome of pneumonia
Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity
Year: 2010
Prognostic usefulness of severity scales for the initial assessment of elderly people with a diagnosis of pneumonia due to COVID-19. Design of a multivariate predictive model of mortality.
Source: Virtual Congress 2021 – COVID - 19 risk predictions
Year: 2021
Performance of the CORB score for predicting clinical outcomes in community-acquired pneumonia.
Source: Virtual Congress 2021 – Pneumonia
Year: 2021
Prognostic evaluation of COPD patients with pneumonia
Source: Eur Respir J 2005; 26: Suppl. 49, 257s
Year: 2005
Value of bacteraemia as an unfavourable prognostic factor for community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 350s
Year: 2006
Predictive value of multiorgan imaging biomarkers for predicting exacerbations in COPD patients
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018
Usefulness of CURB-65, PSI and MuLBSTA in predicting COVID-19 mortality
Source: Virtual Congress 2021 – COVID - 19 risk predictions
Year: 2021
Importance of admission biomarkers in prognostication of patients with SARS-Cov-2
Source: Virtual Congress 2021 – COVID-19 and acute respiratory failure
Year: 2021
Usefulness of procalcitonin as a predictor for bacteremia and prognosis in severe sepsis
Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism
Year: 2016
Role of chest ultrasonography in prognosis of community-acquired pneumonia
Source: International Congress 2016 – A view into a chest and pleural pathology
Year: 2016
Comparison of biomarkers and SOFA score prognostic value in ventilator-associated pneumonia
Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia
Year: 2009
Correlation of procalcitonin and CRP in community-acquired pneumonia with CRB-65 score and prognosis – results from the German competence network CAPNETZ
Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia
Year: 2006
The role of procalcitonin in predicting severity and clinical course of aspiration pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015
Procalcitonin and D-dimer to predict prognosis and clinical outcomes in severe community-acquired pneumonia (SCAP) patients
Source: Annual Congress 2012 - Respiratory infections: a clinical point of view
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept